REED - Revista Española de Enfermedades Digestivas

New issue alert	Contact
Submit a manuscript	Follow REEDigestivas_
Versión en español

Year 2020 / Volume 112 / Number 1
Special Article

Principles for implementing a population screening strategy for hepatitis C in Spain

64-70

DOI: 10.17235/reed.2019.6768/2019

Joaquín Cabezas, Federico García, José Luis Calleja Panero, María Buti, José María Molero García, Antonio Javier Blasco, Pablo Lázaro de Mercado, Javier Crespo,

Abstract

Background: hepatitis C, besides health impairment, results in significant loss of productivity and diminished quality of life, and noticeably contributes to health expenditure increases. Because of all this, the Spanish Ministry of Health (Ministerio de Sanidad, Consumo y Bienestar Social – MSCBS) implemented in 2015 a strategic plan for managing hepatitis C (Plan Estratégico para el Abordaje de la Hepatitis C – PEAHC) within the National Health System. However, the PEAHC includes no screening plan. The MSCBS developed a framework document on population screening (Documento Marco sobre Cribado Poblacional) that defines the criteria a disease must meet in order to consider implementing a screening program. Specifically, it defines 4 criteria related to the health issue, 4 related to the screening test, and 3 criteria dealing with diagnosis confirmation and treatment. Objective: to identify whether there is scientific evidence to support hepatitis C meeting the criteria to be considered a disease qualifying for a population screening strategy in Spain. Methods: a literature search for scientific evidence concerning each required criterion for implementing a population screening plan for hepatitis C in Spain. Results: sufficient scientific evidence was found to support hepatitis C meeting the criteria required by the MSCBS for the implementation of a population screening program. Conclusions: according to the available scientific evidence, hepatitis C in Spain meets the required criteria to qualify for consideration of population screening plan.

New comment

Comments

No comments for this article

References

1. Chen Q, Ayer T, Bethea E, et al. Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study. BMJ Open. 2019;9:e026726.

DOI: 10.1136/bmjopen-2018-026726

2. Cooke GS, Andrieux-Meyer I, Applegate TL, et al. Accelerating the elimination of viral hepatitis: A Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2019;4:135-84. Fe de erratas: Lancet Gastroenterol Hepatol. 2019;4(5):e4.

DOI: 10.1016/S2468-1253(19)30099-8

3. Grupo de trabajo del estudio de prevalencia de la infección por hepatitis C en población general en España; 2017-2018. Resultados del 2º Estudio de Seroprevalencia en España (2017-2018). Ministerio de Sanidad, Consumo y Bienestar Social; 2019.

4. Aguinaga A, Diaz-Gonzalez J, Perez-Garcia A, et al. The prevalence of diagnosed and undiagnosed hepatitis C virus infection in Navarra, Spain, 2014-2016. Enferm Infecc Microbiol Clin. 2018;36:325-31.

DOI: 10.1016/j.eimc.2016.12.008

5. Rodríguez-Tajes S, Dacal Y, Collazos C, et al. Estudio de prevalencia de infección por los virus hepatitis B y C en Cataluña. 42 congreso anual de la Asociación Española para el Estudio del Hígado. Madrid, 16 de febrero de 2017.

6. Fernández-Bermejo M, Íñiguez R, Mata P, et al. Estudio de prevalencia de serología de hepatitis C en un área de salud con población rural. 42 congreso anual de la Asociación Española para el Estudio del Hígado. Madrid, 15-17 de febrero de 2017.

7. Cuadrado A, Perello C, Llerena S, et al. Design and cost effectiveness of a hepatitis C virus elimination strategy based on an updated epidemiological study (ETHON cohort). J Hepatol 2018; Supplement 1, S164.

DOI: 10.1016/S0168-8278(18)30540-3

8. Secretaría General de Sanidad y Consumo. Ministerio de Sanidad, Consumo y Bienestar Social. Plan Estratégico para el Abordaje de la Hepatitis C en el Sistema Nacional de Salud (PEAHC). Octubre 2018. [Citado: 19 de octubre de 2019]. Disponible en: https://www.mscbs.gob.es/ciudadanos/enfLesiones/enfTransmisibles/hepatitisC/PlanEstrategicoHEPATITISC/home.htm

9. Greenaway C, Makarenko I, Chakra CNA, et al. The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic Review. Int J Environ Res Public Health. 2018;15(9).

DOI: 10.3390/ijerph15092013

10. World Health Organization Regional Office for Europe. Action Plan for the Health Sector Response to Viral Hepatitis in the WHO European Region; WHO/Europe: Copenhagen, Denmark, 2016.

11. World Health Organization. Combating hepatitis B and C to reach elimination by 2030. Advocacy brief. WHO: Geneva, Switzerland, May, 2016.

12. UK National Screening Committee. The definition of screening. [Citado: 9 de octubre de 2019]. Disponible en: https://webarchive.nationalarchives.gov.uk/20150408180051/http://www.screening.nhs.uk/screening.

13. Ministerio de Sanidad y Política Social. Documento marco sobre cribado poblacional. Diciembre de 2010. [Citado: 7 de octubre de 2019]. Disponible en: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/documentomarcoCribado.htm

14. Strong K, Wald N, Miller A, et al. Current concepts in screening for noncommunicable disease: World Health Organization Consultation Group Report on methodology of noncommunicable disease screening. J Med Screen. 2005;12:12-9.

DOI: 10.1258/0969141053279086

15. Servicio Cántabro de Salud. Estrategia para la eliminación de la hepatitis C en Cantabria. Consultado el 31 de octubre de 2019. Disponible en: http://www.scsalud.es/documents/ 2162705/2529917/Hepatitis+C.pdf

16. Servicio Canario de Salud. Plan de Prevención de la Infección por Hepatitis en Canarias. Consultado el 31 de octubre de 2019. Disponible en: https://www3.gobiernodecanarias.org/sanidad/scs/contenidoGenerico.jsp?idDocument=25f382f5-46d9-11e3-a0f5-65699e4ff786&idCarpeta=5993c79b-a98e-11dd-b574-dd4e320f085c

17. Consejería de Sanidad. Dirección General de Coordinación de Atención al Ciudadano y Humanización de la Asistencia Sanitaria. Libro Blanco de la Hepatitis C en la Comunidad de Madrid 2016-2019. Edición: Julio 2017. Consultado el 31 de octubre de 2019. Disponible en: http://www.comunidad.madrid/publicacion/1354663261085

18. Crespo J, Albillos A, Buti M, et al. Eliminación de la hepatitis C. Documento de posicionamiento de la Asociación Española para el Estudio del Hígado (AEEH). Gastroenterol Hepatol. 2019;42:579-92.

DOI: 10.1016/j.gastrohep.2019.09.002

19. Younossi Z, Park H, Henry L, et al. Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden. Gastroenterology. 2016;150:1599-608.

DOI: 10.1053/j.gastro.2016.02.039

20. Oliva-Moreno J, Pena-Longobardo LM, Alonso S, et al. Labour productivity losses caused by premature death associated with hepatitis C in Spain. Eur J Gastroenterol Hepatol. 2015;27:631-7.

DOI: 10.1097/MEG.0000000000000336

21. Calleja JL, Lens S, Fernández-Bermejo M, et al. Definition of the profiles of hepatitis C virus patients based on the identification of risky practices in Spain. Rev Esp Enferm Dig 2019; 111:731-37.

DOI: 10.17235/reed.2019.6169/2019

22. WHO guidelines on hepatitis B and C testing. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO.

23. Alarcón-Linares ME, Torres-Cantero A, Subirá C, et al. Geographic analysis and estimation of hepatitis C cases in migrant populations living in Spain: is a country-based screening strategy appropriate?. Rev Esp Enferm Dig 2019; 111:615-25.

DOI: 10.17235/reed.2019.6117/2018

24. Brochado-Kith Ó, Gómez Sanz A, Real LM, et al. MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection. J Clin Med. 2019;8(6). pii: E849. doi: 10.3390/jcm8060849.

DOI: 10.3390/jcm8060849

25. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69:182-236.

DOI: 10.1016/j.jhep.2018.03.019

26. Papatheodoridis GV, Hatzakis A, Cholongitas E, et al. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe. J Viral Hepat. 2018;25 Suppl 1:6-17.

DOI: 10.1111/jvh.12875

27. Gomez-Escolar L, García A, Sáez I, et al. Screening of hepatitis C virus infection in adult general population in Spain. Eur J Gastroenterol Hepatol. 2018;30:1077-81.

DOI: 10.1097/MEG.0000000000001190

28. Buti M, Dominguez-Hernandez R, Casado MA, et al. Healthcare value of implementing hepatitis C screening in the adult general population in Spain. PLoS One. 2018;13(11):e0208036.

DOI: 10.1371/journal.pone.0208036

29. European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2018. J Hepatol. 2018;69:461-511.

DOI: 10.1016/j.jhep.2018.03.026

30. Crespo J, Eiros JM, Blasco AJ, et al. The efficiency of several one-step testing strategies for the diagnosis of hepatitis C. Rev Esp Enferm Dig. 2019;111:10-6. doi: 10.17235/reed.2018.5810/2018.

DOI: 10.17235/reed.2018.5810/2018

31. Chevaliez S, Poiteau L, Rosa I, et al. Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care Clin Microbiol Infect 2016; 22: 459.e1-459.e6.

DOI: 10.1016/j.cmi.2016.01.009

32. Shivkumar S, Peeling R, Jafari Y, et al. Accuracy of Rapid and Point-of-Care Screening Tests for Hepatitis C: A Systematic Review and Meta-analysis. Ann Intern Med. 2012;157:558-66.

DOI: 10.7326/0003-4819-157-8-201210160-00006

33. García F, Domínguez-Hernández R, Casado M, et al. The simplification of the diagnosis process of chronic hepatitis C is cost-effective strategy. Enferm Infecc Microbiol Clin. 2019; pii: S0213-005X(19)30143-0. doi: 10.1016/j.eimc.2019.03.001. [Epub ahead of print]

DOI: 10.1016/j.eimc.2019.03.001. [Epub ahead of print]

34. Canadian Task Force on Preventive Health Care. Recommendations on hepatitis C screening for adults. CMAJ. 2017;189:E594-604.

DOI: 10.1503/cmaj.161521

35. Screening for hepatitis C virus: a systematic review. Ottawa: CADTH; 2017 Mar. (CADTH health technology assessment; no.144).

36. Moyer VA; U.S. Preventive Services Task Force. Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;159:349-57.

DOI: 10.7326/0003-4819-159-5-201309030-00672

37. World Health Organization. Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection: Updated Version. 2016.

38. Hepatitis C Virus Infection Consensus Statement Working Group. Australian recommendations for the management of hepatitis C virus infection: a consensus statement (September 2018). Melbourne: Gastroenterological Society of Australia, 2018.

39. Buti M, Crespo J, García F. Diagnóstico de la hepatitis C en un solo paso. Consultado el 13 de noviembre de 2019. Disponible en: https://seimc.org/ficheros/gruposdeestudio/gehep/dcientificos/documentos/gehep-dc-2018-Diagnostico_en_un_paso_HepatitisC.pdf/3707-2618

40. Crespo J, Lázaro de Mercado P, Blasco Bravo AJ, et al. Diagnosis of hepatitis C virus infection in Spain: An opportunity to improve. Enferm Infecc Microbiol Clin. 2019;37:231-8.

DOI: 10.1016/j.eimc.2018.05.016

41. AASLD-IDSA HCV Guidance Panel. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis. 2018;67:1477-92.

DOI: 10.1093/cid/ciy585

42. Marks K, Naggie S. Management of Hepatitis C in 2019. JAMA. 2019 May 17. doi: 10.1001/jama.2019.5353. [Epub ahead of print].

DOI: 10.1001/jama.2019.5353. [Epub ahead of print]

43. Cooke GS, Andrieux-Meyer I, Applegate TL, et al. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2019;4:135-84.

DOI: 10.1016/S2468-1253(18)30270-X

44. Buti M, Calleja JL, Garcia-Samaniego J, et al. Elimination of hepatitis C in Spain: Adaptation of a mathematical model based on the public health strategic plan for addressing hepatitis C in the National Health System. Med Clin (Barc ). 2017;148:277-82.

DOI: 10.1016/j.medcli.2016.12.018

45. Goñi S, Juanbeltz R, Martínez-Baz I, et al. Long-term changes on health-related quality of life in patients with chronic hepatitis C after viral clearance with direct-acting antiviral agents. Rev Esp Enferm Dig. 2019;111:445-52.

46. Ministerio de Sanidad, Servicios Sociales e Igualdad. Plan estratégico para el abordaje de la hepatitis C en el sistema nacional de salud. Actualización línea estratégica 2. Madrid; 2017. Consultado el 27 de septiembre de 2019. Disponible en: https://www.mscbs.gob.es/ciudadanos/enfLesiones/enfTransmisibles/hepatitisC/PlanEstrategicoHEPATITISC/docs/actualizacionEstrategiaTerapeuticaJunio2017.pdf

47. Mar J, Ibarrondo O, Martinez-Baz I, et al. Economic evaluation of a population strategy for the treatment of chronic hepatitis C with direct-acting antivirals. Rev Esp Enferm Dig. 2018;110:621-8.

DOI: 10.17235/reed.2018.5605/2018

48. Turnes J, Dominguez-Hernandez R, Casado MA. Value and innovation of direct-acting antivirals: long-term health outcomes of the strategic plan for the management of hepatitis C in Spain. Rev Esp Enferm Dig. 2017;109:809-17.

DOI: 10.17235/reed.2017.5063/2017

49. Guías AEEH/SEIMC de manejo de la Hepatitis C. 2107. Consultado el 1 de octubre de 2019. Disponible en: http://aeeh.es/wp-content/uploads/2017/06/consenso.pdf

50. Albillos A, Cañada JL, Molero JM, Pérez S, Pérez F, Simón MA, Turnes J; AEEH, SEMERGEN, semFYC, SEMG. Consenso de recomendaciones para el diagnóstico precoz, la prevención y la atención clínica de la hepatitis C en Atención Primaria. Madrid: Luzán 5; 2017.

51. Terrault NA, Hassanein T. Management of the patient with SVR. J Hepatol. 2016;65(1 Suppl):S120-S129.

DOI: 10.1016/j.jhep.2016.08.001

52. Carrat F, Fontaine H, Dorival C, et al. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet. 2019;393:1453-64.

DOI: 10.1016/S0140-6736(18)32111-1

53. Alavi M, Law MG, Valerio H, et al. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia. J Hepatol. 2019;71:281-8.

DOI: 10.1016/j.jhep.2019.04.014

54. Pascasio JM, Vinaixa C, Ferrer MT, et al. Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation. J Hepatol. 2017;67:1168-76.

DOI: 10.1016/j.jhep.2017.08.008

55. Crespo G, Trota N, Londoño MC, et al. The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition. J Hepatol. 2018;69:11-7.

DOI: 10.1016/j.jhep.2018.02.012

56. Kanwal F, Kramer J, Asch SM, et al. Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents. Gastroenterology. 2017;153:996-1005.

DOI: 10.1053/j.gastro.2017.06.012

57. Kanwal F, Kramer JR, Asch SM, et al. Long-Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents. Hepatology. 2019 Jun 20. doi: 10.1002/hep.30823. [Epub ahead of print].

DOI: 10.1002/hep.30823. [Epub ahead of print]

58. Cacoub P, Desbois AC, Comarmond C, et al. Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis. Gut. 2018;67:2025-34.

DOI: 10.1136/gutjnl-2018-316234

59. Butt AA, Yan P, Shuaib A, et al. Direct-Acting Antiviral Therapy for HCV Infection Is Associated With a Reduced Risk of Cardiovascular Disease Events. Gastroenterology. 2019;156:987-96.

DOI: 10.1053/j.gastro.2018.11.022

60. Sacristán JA, Oliva J, Campillo-Artero C, et al. ¿Qué es una intervención sanitaria eficiente en España en 2020? Gac Sanit. 2019. https://doi.org/10.1016/j.gaceta.2019.06.007 [Epub ahead of print].

61. Lazarus JV, Picchio C, Dillon JF, et al. Too many people with viral hepatitis are diagnosed late-with dire consequences. Nat Rev Gastroenterol Hepatol. 2019;16:451-2.

DOI: 10.1038/s41575-019-0177-z

62. Crespo J, Cuadrado A, Perelló C, et al. Epidemiology of hepatitis C virus infection in a country with universal access to direct-acting antiviral agents: data for designing a cost-effective elimination policy in Spain. J Viral Hepat. 2019 Nov 22. doi: 10.1111/jvh.13238. [Epub ahead of print].

DOI: 10.1111/jvh.13238. [Epub ahead of print]

Editorial

Population screening for colorectal cancer in Spain - A public health success with remaining challenges

DOI: 10.17235/reed.2024.10774/2024

Special Article

Strategic analysis and recommendations of the Sociedad Española de Patología Digestiva (SEPD) regarding population-based screening programs for colorectal cancer in Spain

DOI: 10.17235/reed.2024.10458/2024

Original

Screening and risk of hepatocellular carcinoma in patients with advanced fibrosis after hepatitis C virus eradication

DOI: 10.17235/reed.2024.9945/2023

Letter

Pancreatic schwannomaPancreatic schwannoma: a rare tumor of the pancreasa rare tumor of the pancreas

DOI: 10.17235/reed.2023.9840/2023

Letter

Is cervical dysplasia a major concern in females with inflammatory bowel disease? A Spanish retrospective study

DOI: 10.17235/reed.2023.9890/2023

Letter

Better prognosis of HCV patients diagnosed and treated with an automatic alert system

DOI: 10.17235/reed.2023.9835/2023

Letter

Dissemination of the automated alert system in the diagnosis and treatment of hepatitis C

DOI: 10.17235/reed.2023.9801/2023

Letter

Calcifying fibrous tumor and pathological analysis

DOI: 10.17235/reed.2023.9739/2023

Letter

Endoscopic observation of a rare duodenal tumor

DOI: 10.17235/reed.2023.9679/2023

Editorial

Recent advances in the diagnosis and management of Wilson’s disease

DOI: 10.17235/reed.2023.9633/2023

Special Article

Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver

DOI: 10.17235/reed.2022.9325/2022

Letter

Vaginal lesion as first manifestation of colorectal disease

DOI: 10.17235/reed.2022.9270/2022

Letter

Hepatitis C virus micro-elimination in vulnerable populations before and during a global pandemic

DOI: 10.17235/reed.2022.9275/2022

Letter

Intrahepatic sarcomatoid cholangiocarcinoma: a rare cholangiocarcinoma subtype

DOI: 10.17235/reed.2022.9130/2022

Digestive Diseases Image

High-grade intraepithelial neoplasia of the cervical esophagus arising from a tiny ectopic gastric mucosa

DOI: 10.17235/reed.2022.9007/2022

Letter

Importance of immunohistochemistry in the differential diagnosis of gastric mesenchymal tumors

DOI: 10.17235/reed.2022.8923/2022

Special Article

Current state of telemedicine in the field of Hepatology in Spain: challenges, threats and next steps to follow for an intelligent digital transformation

DOI: 10.17235/reed.2022.8918/2022

Letter

Diagnosis and treatment of a small intestinal neuroendocrine neoplasm by double balloon enteroscopy combined with laparoscopy: a case report

DOI: 10.17235/reed.2022.8900/2022

Letter

Extensive intramural hematoma of the esophagus: a rare complication of esophageal thermal injury

DOI: 10.17235/reed.2022.8861/2022

Editorial

Risk of hepatocellular carcinoma in patients with chronic hepatitis c infection and stage 3 fibrosis after sustained virological response

DOI: 10.17235/reed.2022.8840/2022

Letter

An uncommon case of gastrointestinal bleeding: Meckel’s diverticulum with ectopic gastric mucosa

DOI: 10.17235/reed.2022.8831/2022

Letter

Impact of the SARS-CoV-2 pandemic on pancreatic cancer: diagnosis and short-term survival

DOI: 10.17235/reed.2022.8772/2022

Digestive Diseases Image

An unusual cause of a protuberant lesion of the gastric antrum

DOI: 10.17235/reed.2022.8771/2022

Letter

Sigmoid colon Schwannoma simulating colon cancer

DOI: 10.17235/reed.2022.8684/2022

Original

Hepatitis C virus infection screening reduces mortality and is cost-effective independently of the intervention test

DOI: 10.17235/reed.2022.8609/2022

Original

Outcomes of an automated alert system from Microbiology to link diagnosis to treatment in patients with hepatitis C virus

DOI: 10.17235/reed.2022.8716/2022

Original

Comparison of diagnostic accuracy between linear EUS and miniprobe EUS for submucosal invasion in suspected cases of early gastric cancer.

DOI: 10.17235/reed.2022.8512/2021

Original

EUS-guided fine-needle liver biopsy in pediatric patients using a modified technique with one-pass, one-actuation wet suction

DOI: 10.17235/reed.2022.8503/2021

Original

A slowdown of hepatitis C diagnosis in high-prevalence groups and with decentralized diagnostic strategies during the COVID-19 pandemic

DOI: 10.17235/reed.2022.8412/2021

Original

Findings in the distal and proximal colon in colonoscopy screening after positive FIT and related pre-procedure factors

DOI: 10.17235/reed.2022.8409/2021

Editorial

Cases of liver disease lost in the health system: a call to action

DOI: 10.17235/reed.2021.8316/2021

Original

Active search for hepatitis C patients in primary care

DOI: 10.17235/reed.2021.8067/2021

Digestive Diseases Image

Abdominal cocoon sign: an unusual cause of intestinal obstruction

DOI: 10.17235/reed.2021.8057/2021

Letter

POEMS syndrome: an uncommon cause of peritoneal effusion

DOI: 10.17235/reed.2021.8027/2021

Letter

Chronic viral hepatitis C micro-elimination program using telemedicine. The Mexican experience

DOI: 10.17235/reed.2021.7829/2021

Letter

Telemedicine, time to change the paradigm of hepatitis C management: improve access and reduce costs In reference to: Chronic viral hepatitis C micro-elimination program using telemedicine. The Mexican experience, by Pérez Hernández et al.

DOI: 10.17235/reed.2021.7809/2021

Original

Hepatitis C in homeless people: reaching a hard-to-reach population

DOI: 10.17235/reed.2021.7737/2020

Letter

The Screening Guidelines for Hepatitis C Virus Infection as a milestone in the path towards hepatitis C virus elimination

DOI: 10.17235/reed.2021.7736/2020

Editorial

Screening guide for hepatitis C virus infection in Spain

DOI: 10.17235/reed.2020.7728/2020

Original

Resumption of endoscopy in the Galician colorectal cancer screening programme after the COVID-19 lock down: patient safety results

DOI: 10.17235/reed.2020.7647/2020

Original

Chronic hepatitis C patients lost in the system: predictive factors of non-referral or loss of follow-up in Hepatology units

DOI: 10.17235/reed.2020.7573/2020

Original

Detection of anti-kelch-like 12 and anti-hexokinase 1 antibodies in primary biliary cholangitis patients in China

DOI: 10.17235/reed.2020.7483/2020

Original

Chronic viral hepatitis C micro-elimination program using telemedicine. The Mexican experience

DOI: 10.17235/reed.2020.7425/2020

Digestive Diseases Image

Phlebosclerotic colitis: an unusual cause of abdominal pain and hematochezia

DOI: 10.17235/reed.2020.7358/2020

Digestive Diseases Image

Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of a case of a huge abdominal mass

DOI: 10.17235/reed.2020.7305/2020

Original

Prevalence of hepatitis C in patients with non-affective psychotic disorders

DOI: 10.17235/reed.2020.7278/2020

Letter

Ribavirin monotherapy for the treatment of chronic hepatitis E in an immunosuppressed patient

DOI: 10.17235/reed.2020.7266/2020

Review

New non-invasive biomarkers for colorectal cancer screening

DOI: 10.17235/reed.2020.7233/2020

Original

Linkage to care strategy for the micro-elimination of hepatitis C among parenteral drug users on methadone replacement therapy in Gipuzkoa

DOI: 10.17235/reed.2020.7194/2020

Original

Role of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and classification of lymphomas

DOI: 10.17235/reed.2020.7191/2020

Letter

It seems like cholangiocarcinoma but it is not: discovering the choledochal cyst

DOI: 10.17235/reed.2020.7114/2020

Special Article

Strategy for the Elimination of Hepatitis C in Cantabria

DOI: 10.17235/reed.2020.7108/2020

Editorial

Reflex testing. A key tool for the elimination of hepatitis C

DOI: 10.17235/reed.2020.7201/2020

Letter

Hepatitis C and beta-thalassemia major in children: experience with glecaprevir/pibrentasvir

DOI: 10.17235/reed.2020.7092/2020

Original

Patients with hepatitis C lost to follow-up: ethical-legal aspects and search results

DOI: 10.17235/reed.2020.7077/2020

Letter

Pseudoaneurysm of the gastroduodenal artery with arterio-duodenal fistulization secondary to acute pancreatitis: an unusual endoscopic diagnosis

DOI: 10.17235/reed.2020.7070/2020

Letter

Chilaiditi’s and Ogilvie syndromes

DOI: 10.17235/reed.2020.7036/2020

Original

Changes in the characteristics of hospital admissions due to decompensated cirrhosis in the era of direct-acting antivirals against hepatitis C virus

DOI: 10.17235/reed.2020.7024/2020

Original

Prevalence and detection of undiagnosed active hepatitis C virus infections in Navarre, Spain, 2017-2019

DOI: 10.17235/reed.2020.7000/2020

Original

Diabetes is not associated with an increased risk of hepatocellular carcinoma in patients with alcoholic or hepatitis C virus cirrhosis

DOI: 10.17235/reed.2020.6953/2020

Original

Recapture of patients with an incomplete diagnosis of hepatitis C virus infection

DOI: 10.17235/reed.2020.6944/2020

Original

Review of hepatitis C screening programs for immigrants in Spain from endemic countries

DOI: 10.17235/reed.2020.6916/2020

Letter

Spontaneous clearance of chronic hepatitis C in an immunocompetent patient

DOI: 10.17235/reed.2020.6909/2020

Letter

Hepatocarcinoma diagnosis. Reflection is required

DOI: 10.17235/reed.2020.6845/2019

Original

Differences between residual and primary choledocholithiasis in cholecystectomy patients

DOI: 10.17235/reed.2020.6760/2019

Original

Surgical management of Boerhaave’s syndrome with early and delayed diagnosis in adults: a retrospective study of 88 patients

DOI: 10.17235/reed.2020.6746/2019

Special Article

Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)

DOI: 10.17235/reed.2019.6700/2019

Letter

Successful evolution of morphea after hepatitis C virus eradication with direct-acting antiviral agent treatment

DOI: 10.17235/reed.2019.6461/2019

Original

Towards the elimination of hepatitis C: implementation of reflex testing in Andalusia

DOI: 10.17235/reed.2020.6370/2019

Original

Quality of life study in asymptomatic patients with hepatitis C

DOI: 10.17235/reed.2019.6339/2019

Original

Definition of the profiles of hepatitis C virus patients based on the identification of risky practices in Spain

DOI: 10.17235/reed.2019.6169/2019

Original

The contribution of telemedicine to hepatitis C elimination in a correctional facility

DOI: 10.17235/reed.2019.6152/2018

Original

Geographic analysis and estimation of hepatitis C cases in migrant populations living in Spain: is a country-based screening strategy appropriate?

DOI: 10.17235/reed.2019.6117/2018

Original

Long-term changes on health-related quality of life in patients with chronic hepatitis C after viral clearance with direct-acting antiviral agents

DOI: 10.17235/reed.2019.6063/2018

Letter

Acute seronegative hepatitis C: two case reports

DOI: 10.17235/reed.2019.5921/2018

Editorial

Colorectal cancer screening and survival

DOI: 10.17235/reed.2018.5870/2018

Review

Meta-analysis of the diagnostic value of contrast-enhanced ultrasound for the detection of vascular complications after liver transplantation

DOI: 10.17235/reed.2018.5818/2018

Original

The efficiency of several one-step testing strategies for the diagnosis of hepatitis C

DOI: 10.17235/reed.2018.5810/2018

Original

Klatskin tumors and “Klatskin-mimicking lesions”: our 22-year experience.

DOI: 10.17235/reed.2018.5749/2018

Letter

An unusual case report of inflammatory fibrous polyps in the upper gastrointestinal tract

DOI: 10.17235/reed.2018.5734/2018

Letter

Why anal cytology is not enough in a dysplasia screening program

DOI: 10.17235/reed.2018.5678/2018

Original

Primary biliary cholangitis in Spain. Results of a Delphi study of epidemiology, diagnosis, follow-up and treatment

DOI: 10.17235/reed.2018.5665/2018

Review

Meckel’s diverticulum: clinical features, diagnosis and management

DOI: 10.17235/reed.2018.5628/2018

Letter

Anal intraepitelial neoplasia: how and for who do we perform a screening program?

DOI: 10.17235/reed.2018.5616/2018

Original

Economic evaluation of a population strategy for the treatment of chronic hepatitis C with direct-acting antivirals

DOI: 10.17235/reed.2018.5605/2018

Case Report

Endoscopic closure of tracheoesophageal fistula for tuberculosis with an over-the-scope-clip

DOI: 10.17235/reed.2018.5563/2018

Case Report

Healing of autoimmune hepatitis associated with hepatitis C virus infection treated with direct-acting antivirals

DOI: 10.17235/reed.2018.5528/2018

Original

Screening-detected colorectal cancers show better long-term survival compared with stage-matched symptomatic cancers

DOI: 10.17235/reed.2018.5509/2018

Original

Long noncoding RNAs as diagnostic biomarkers for the early detection of digestive tract cancers: a systematic review and meta-analysis

DOI: 10.17235/reed.2020.5450/2018

Original

Endoscopic ultrasound cytologic brushing vs endoscopic ultrasound - fine needle aspiration for cytological diagnosis of cystic pancreatic lesions. A multicenter, randomized open-label trial

DOI: 10.17235/reed.2018.5449/2017

Original

Analysis of the diagnostic yield of endoscopic ultrasonography-guided fine-needle aspiration in patients with a suspected pancreatic malignancy

DOI: 10.17235/reed.2018.5455/2017

Editorial

Disruptive therapeutic innovation and the opportunity to eliminate a chronic disease – The issue of chronic hepatitis C in Spain

DOI: 10.17235/reed.2017.5384/2017

Special Article

Recommendations to report and interpret HLA genetic findings in coeliac disease

DOI: 10.17235/reed.2018.5269/2017

Original

Effectiveness of direct-acting antiviral therapy in patients with a HCV/HIV coinfection. A multicenter cohort study

DOI: 10.17235/reed.2017.5210/2017

Case Report

Liver transplantation in hemophilia A and von Willebrand disease type 3: perioperative management and post-transplant outcome

DOI: 10.17235/reed.2018.5204/2017

Review

Intestinal tuberculosis and Crohn’s disease: the importance and difficulty of a differential diagnosis

DOI: 10.17235/reed.2018.5184/2017

Original

Value and innovation of direct-acting antivirals: long-term health outcomes of the strategic plan for the management of hepatitis C in Spain

DOI: 10.17235/reed.2017.5063/2017

Editorial

Lower morbidity and improved outcomes in patients with screen-detected colorectal cancer

DOI: 10.17235/reed.2017.5107/2017

Letter to the Editor

Hepatitis with a multiple etiology in HIV-positive men who have sexual relations with other men

DOI: 10.17235/reed.2017.5033/2017

Letter to the Editor

Sternal cutaneous metastasis of hilar cholangiocarcinoma

DOI: 10.17235/reed.2017.4979/2017

Original

Anal cytology, histopathology and anoscopy in an anal dysplasia screening program: is anal cytology enough?

DOI: 10.17235/reed.2017.4913/2017

Original

Clinical manifestations and endoscopic presentations of gastric lymphoma: a multicenter seven year retrospective survey

DOI: 10.17235/reed.2017.4882/2017

Editorial

Target population for the screening of human papillomavirus (HPV) and anal carcinoma precursor lesions – Results from a pilot study in HIV-infected males with sexual risk factors

DOI: 10.17235/reed.2017.4939/2017

Case Report

Liver metastasis from neuroendocrine carcinoma after the use of the new direct-action antivirals against hepatitis C virus in a patient with past history of hepatocellular carcinoma

DOI: 10.17235/reed.2017.4772/2016

Original

Cost-effectiveness of a hepatitis B virus screening strategy to prevent reactivation in patients with hematologic neoplasms

DOI: 10.17235/reed.2017.4693/2016

Letter to the Editor

Hepatocellular carcinoma in patients without advanced fibrosis after HCV eradication antiviral treatment

DOI: 10.17235/reed.2017.4677/2016

Original

Is it possible to predict the presence of colorectal cancer in a blood test? A probabilistic approach method

DOI: 10.17235/reed.2017.4645/2016

Original

The impact of screening on short-term outcome after surgery for colorectal cancer

DOI: 10.17235/reed.2017.4569/2016

Original

Malnutrition risk questionnaire combined with body composition measurement in malnutrition screening in inflammatory bowel disease

DOI: 10.17235/reed.2016.4557/2016

Digestive Diseases Image

Hepatocellular carcinoma presenting with Budd-Chiari syndrome, right atrial thrombus and pulmonary emboli

Letter to the Editor

About human taeniasis and Taenia saginata diagnosis by endoscopy

DOI: 10.17235/reed.2016.4297/2016

Original

Preliminary results of a screening program for anal cancer and its precursors for HIV-infected men who have sex with men in Vigo-Spain

DOI: 10.17235/reed.2017.4274/2016

Digestive Diseases Image

Endoscopic removal of multiple sharp gastro-duodenal foreign bodies

Original

Effectiveness of three interventions to improve participation in colorectal cancer screening

DOI: 10.17235/reed.2016.4048/2015

Original

Enhanced flat adenoma detection rate with high definition colonoscopy plus i-scan for average-risk colorectal cancer screening

DOI: 10.17235/reed.2016.4008/2015

Review

Causes of treatment failure for hepatitis C in the era of direct-acting antiviral therapy

DOI: 10.17235/reed.2015.3894/2015

Original

Efficacy and safety of simeprevir in combination with peginterferon and ribavirin for patients with hepatitis C genotype 1 infection: A meta-analysis of randomized trials

DOI: 10.17235/reed.2015.3840/2015

Letter to the Editor

TIPS treatment in a patient with severe lower gastrointestinal bleeding with a misdiagnosis of cirrhotic portal hypertension

DOI: 10.17235/reed.2015.3794/2015

Original

Impact of the age of diagnosis on the natural history of ulcerative colitis

DOI: 10.17235/reed.2015.3736/2015

Case Report

Endoscopy as a diagnostic and therapeutic alternative technique of taeniasis

DOI: 10.17235/reed.2015.3585/2014

Citation tools

Cabezas J, García F, Calleja Panero J, Buti M, Molero García J, Blasco A, et all. Principles for implementing a population screening strategy for hepatitis C in Spain. 6768/2019

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics

This article has received 2439 visits.
This article has been downloaded 301 times.

Statistics from Dimensions

Statistics from Plum Analytics

Publication history

Received: 25/11/2019

Accepted: 06/12/2019

Online First: 27/12/2019

Published: 10/01/2020

Article revision time: 7 days

Article Online First time: 32 days

Article editing time: 46 days

This article hasn't been rated yet.

Reader rating:

Valora este artículo:

Submission and tracking of manuscripts

Instructions to authors

Submission and tracking

Home

Articles

Current issues

Previous issues

Cookie	Purpose	Expiration	Cookie type
ASP.NET_SessionId	Makes it possible to control traffic from the server to multiple users at the same time, identification and access as a user.	Logout / End of project	Session
cookiesDirective	Makes it possible to remember cookie settings.	Logout / End of project	Session
vercookies	Makes it possible to display the notice on the use of cookies.	Logout / End of project	Session

Download to a citation manager

Statistics from Dimensions

Statistics from Plum Analytics

Submission and tracking of manuscripts

Receive the digital monthly newsletter of the REED

In accordance with current legislation, this publication is only for health care professionals.